Fundz

Who to call at Genethon, and when

Fundz watches for the moments Genethon starts buying, and tells you who to reach.

  • An alert the day Genethon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Genethon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Genethon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Genethon Enters Licensing Agreement with AskBio to Develop Gene Therapy for Pompe Disease.

Jan 14, 2026

Contract Type

agreement

RomeBiotechnologyHealth CareGeneticsTherapeutics

Description

Genethon has signed an exclusive worldwide licensing agreement with AskBio for the use of a patented component of AB-1009 to treat Pompe disease. This collaboration aims to leverage Genethon's research capabilities to develop innovative therapeutic solutions for patients suffering from rare diseases.

Company Information

Company

Genethon

Location

Rome, Lazio, Italy

About

Généthon is a pioneer in the discovery and development of gene therapies for rare diseases, established by the AFM-Téléthon. The organization employs over 200 scientists and professionals dedicated to developing innovative therapies that improve the lives of patients with rare genetic diseases. It is known for its contributions to the field, including the first gene therapy for spinal muscular atrophy. Currently, Genethon has multiple products in clinical trials targeting various conditions.

Related People

Angela
Likely contact at this company
••••••••@••••••••

See Angela's verified email →

Céline
Likely contact at this company
••••••••@••••••••

See Céline's verified email →

Joëlle
Likely contact at this company
••••••••@••••••••

See Joëlle's verified email →

Iris
Likely contact at this company
••••••••@••••••••

See Iris's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Genethon's next move

Learn about Strategic plan

Genethon signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.